A recent study from our institute investigating classification of DCIS by gene expression profiling confirms this finding and identified luminal, Her2-, and basal-like tumours in a series of 40 DCIS lesions (Hannemann et al, 2006). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.